A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer (Q44370429)
Jump to navigation
Jump to search
scientific article published in June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer |
scientific article published in June 2012 |
Statements
1 reference
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer (English)
1 reference
Peter M Ellis
1 reference
Quincy S Chu
1 reference
Natasha Leighl
1 reference
Scott A Laurie
1 reference
Holger Fritsch
1 reference
Birgit Gaschler-Markefski
1 reference
Steve Gyorffy
1 reference
Gerd Munzert
1 reference
1 June 2012
1 reference
1 reference
Identifiers
1 reference